Inspec

Inspec Equity

The The Equity of Inspec (6656.T) as of Oct 21, 2026 is 1.04 B JPY. In the previous year, The Equity was 958.56 M JPY — a change of 8.19% (higher).

Equity

1.04 BJPY

YoY

8.19%

Last updated:

In 2026, Inspec's equity was 1.04 B JPY, a 8.19% increase from the 958.56 M JPY equity in the previous year.

The Inspec Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
1.24 B JPY
Jan 1, 2020
2.05 B JPY
Jan 1, 2021
904.25 M JPY
Jan 1, 2022
1.09 B JPY
Jan 1, 2023
1.41 B JPY
Jan 1, 2024
1.08 B JPY
Jan 1, 2025
958.56 M JPY
Jan 1, 2026
1.04 B JPY
The Inspec Equity history
YEAREquityYoY
1.04 BJPY+8.19%
958.56 MJPY-11.18%
1.08 BJPY-23.32%
1.41 BJPY+29.40%
1.09 BJPY+20.28%
904.25 MJPY-55.91%
2.05 BJPY+65.76%
1.24 BJPY+27.39%
971.25 MJPY+14.33%
849.50 MJPY+33.19%
637.82 MJPY+6.05%
601.44 MJPY+21.56%
494.77 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Inspec's Equity

Inspec's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Inspec's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Inspec's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Inspec's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Inspec’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Inspec stock

The Equity of Inspec is 1.04 B JPY in 2026.

The Equity of Inspec changed from 958.56 M JPY to 1.04 B JPY, representing a 8.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Inspec since 2006 – with annual values, charts, and detailed analysis.

The Equity's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Inspec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Inspec

All Key Metrics — Inspec